DATA SHEET PROGYNOVA - Medsafe
Treatment should be stopped at once if there are symptoms of a thrombotic event or suspicion thereof. Symptoms of venous or arterial thrombosis can include: unilateral
Download DATA SHEET PROGYNOVA - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Core Measures Update: Acute MI, Heart Failure, …
keymedinfo.com1 Core Measures Update: Acute MI, Heart Failure, and Pneumonia Key Medical Resources, Inc. 4.0 Contact Hours California Board of Registered Nursing CEP#15122
Cerebrovascular Accident (Stroke) - ambonsall.com
www.ambonsall.comComplications • Patients with TIA and stroke also have an ↑risk of MI and other vascular events. • Other complications for the patient include: thromboembolism…
PRODUCT INFORMATION MICROGYNON 20 ED …
www.bayerresources.com.au1801 MICROGYNON 20 ED PI 1 PRODUCT INFORMATION MICROGYNON 20 ED . NAME OF THE MEDICINE . MICROGYNON 20 ED is a combined oral contraceptive(COC) tablet containing the
Final Updated 2013 IMS Recommendations - Home …
www.imsociety.org1 CLIMACTERIC 2013;16:316 337 Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for …
Patient Information NuvaRing (etonogestrel/ethinyl ...
www.merck.com3 have an inherited problem with your blood that makes it clot more than normal have had a stroke have had a heart attack have certain heart valve problems or heart rhythm problems that can cause
VTE - moh.gov.my
www.moh.gov.myVTE CLINICAL PRACTICE GUIDELINES Prevention and Treatment of Venous Thromboembolism Malaysian Society of Haematology National Heart Association